This HTML5 document contains 184 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://dx.doi.org/10.1038/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36615251
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ artikel ilmiah teaduslik artikkel vedecký článok научни чланак artigo científico 2005年論文 article scientific wissenschaftlicher Artikel 2005年論文 artigo científico article científic 2005 nî lūn-bûn 2005年论文 bilimsel makale videnskabelig artikel наукова стаття, опублікована у вересні 2005 artikulong pang-agham articol științific সেপ্টেম্বর ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ bài báo khoa học 2005年论文 מאמר מדעי artículu científicu espublizáu en 2005 научна статия 2005年论文 scienca artikolo 2005年论文 scientific article published on September 2005 artykuł naukowy 2005년 논문 2005年論文 مقالة علمية نشرت في سبتمبر 2005 vědecký článek 2005年论文 vitenskapelig artikkel artículo científico publicado en 2005 article scientifique articolo scientifico 2005年の論文 tudományos cikk บทความทางวิทยาศาสตร์ 2005年論文 artigo científico scientific article published on September 2005 vetenskaplig artikel vitskapeleg artikkel επιστημονικό άρθρο научная статья 2005年论文 научни чланак სამეცნიერო სტატია wetenschappelijk artikel 2005年論文 naučni članak artikull shkencor scientific article published on September 2005 tieteellinen artikkeli
p:P577
wds:Q36615251-B4F1F056-D4FF-4839-AC68-3B0585890FA9
wdt:P577
2005-09-01T00:00:00Z
p:P407
wds:Q36615251-5FABB59D-DC11-48D6-87DD-EC6F3CD21941
wdt:P407
wd:Q1860
p:P2888
wds:Q36615251-BA0CE5FF-667A-441A-AA80-96B47B2421D0
wdt:P2888
n13:sj.bjc.6602732
p:P2860
wds:Q36615251-E59DCB62-6D23-4D79-BC3A-07E20AA3B988 wds:Q36615251-F0CED38E-8A57-4B0F-9FC1-8359452441FE wds:Q36615251-F31E5219-094E-4291-B74C-E519C6556B55 wds:Q36615251-DB3DCC86-180D-41D1-A327-D72BE4D2F9E8 wds:Q36615251-DFF36C24-734B-4A1A-B6A3-961A853D0DCF wds:Q36615251-CD1C1693-FF83-4F9D-B7FE-BC70EC675521 wds:Q36615251-C370F889-056E-4655-B456-2A3009091F07 wds:Q36615251-C8E4E415-EF0E-4F89-8F05-3560DB822301 wds:Q36615251-B3BAFF29-BC76-4FF8-8E79-0CA431238AA9 wds:Q36615251-B804E8B3-81F5-4035-9542-740FF9E1A108 wds:Q36615251-AA2EEA05-809C-4DF0-9185-5370EDAFCEB2 wds:Q36615251-AF64140C-736F-4771-8948-1BEBED1E5A29 wds:Q36615251-B28D126E-632C-4723-80F3-EDC38631180D wds:Q36615251-9D656B76-6959-47B0-9948-D2C81D8CCF1F wds:Q36615251-9FA15326-3731-4990-AA9C-892B55805E40 wds:Q36615251-A36C90FA-720E-4C12-9D3C-8C72B094B9BA wds:Q36615251-A94CE2B6-8318-4B02-9989-723B3B484B1D wds:Q36615251-6D5DA050-D327-4EF7-9D15-0A62D3CD4B40 wds:Q36615251-6F4F0B45-E6E1-4807-8F49-8C2D0B05A636 wds:Q36615251-8443012A-0D54-4C61-BF28-27880C9F3E33 wds:Q36615251-F771B066-B4D5-436C-A7D4-91F7DA1AD327 wds:Q36615251-60764785-DBBD-4215-A938-C1615EDFDE95 wds:Q36615251-6C3786F5-CE88-47B7-A096-03D58D353878 wds:Q36615251-51DCD3FE-2EBD-4554-82B1-E1A456E5C496 wds:Q36615251-54D7BC15-FD50-42A7-98B8-6BEECABFCF0C wds:Q36615251-40D8CBAD-DE9D-4071-96B2-5F0B398C5437 wds:Q36615251-4724C61D-81CE-4B2A-ADF2-CEE2BE3E24C1 wds:Q36615251-36DF8259-2CC4-43C7-AC60-BFF22A34255D wds:Q36615251-391FF5A3-42B0-4922-922E-C3B1ABF1FFAC wds:Q36615251-3B23FF35-C8A4-4D30-B33B-F15DC1786802 wds:Q36615251-1059B843-CD0F-470B-9D7B-AF70A2DC749A wds:Q36615251-1215BAAD-3BCE-4B2B-8939-7FFAF67959F8 wds:Q36615251-19CF542B-EA35-4487-BB44-20C378C0F0C0 wds:Q36615251-006D27FC-B535-40CA-B5A7-D554CBFD72C7 wds:Q36615251-0E11DA81-F29C-46FB-A07E-DB0D2A0F0EA6
wdt:P2860
wd:Q74352294 wd:Q41120824 wd:Q57384660 wd:Q53385005 wd:Q73799693 wd:Q42020999 wd:Q40831782 wd:Q77889688 wd:Q38468735 wd:Q28210483 wd:Q79332311 wd:Q79333423 wd:Q43542399 wd:Q28304002 wd:Q24316446 wd:Q22008593 wd:Q78398554 wd:Q40588270 wd:Q36115630 wd:Q74286683 wd:Q36673651 wd:Q71708794 wd:Q38499838 wd:Q73622800 wd:Q53962194 wd:Q48926053 wd:Q36367323 wd:Q36345806 wd:Q41074621 wd:Q44747126 wd:Q42066713 wd:Q34569586 wd:Q46938548 wd:Q72993089 wd:Q45857333
p:P2093
wds:Q36615251-DC74E9BB-8A85-4C67-B112-A68DEAB6E414 wds:Q36615251-ED81B4F0-FB8B-4E1F-9D5A-581CF5B1B844 wds:Q36615251-D5D1DB8F-7CC5-4633-860C-FE55294475D9 wds:Q36615251-CE4A7D54-28E8-4B72-8537-D8A9F0365663 wds:Q36615251-13614001-B40F-4202-BF77-75092C9F0B94 wds:Q36615251-5A654A35-7360-4FD8-8DFD-E829CAF4B678 wds:Q36615251-6647F9BE-9424-45D0-99FF-4D1E20BAFC5A wds:Q36615251-31E53CE7-BFA6-4CA3-B3FD-F905C293C1B6 wds:Q36615251-3FF6892B-6FC2-4307-B63E-CB4EF5F50D7F
wdt:P2093
K Yamana T Kasahara Y Tomita V Bilim R Maruyama N Hara T Nishiyama T Itoi K Takahashi
rdfs:label
Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
skos:prefLabel
Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
schema:name
Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
p:P1476
wds:Q36615251-4B6040C8-4C9F-4BA1-B3B3-14125E27772F
wdt:P1476
Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
p:P304
wds:Q36615251-AE2F0038-15CF-4691-AC0D-99FDBF8A5DB4
wdt:P304
544-551
p:P31
wds:Q36615251-FECD6ED9-F786-46BE-BE1D-614E0E801382
wdt:P31
wd:Q13442814
p:P698
wds:Q36615251-D007E79F-32D6-4981-BC38-59FB61CD1DBC
wdtn:P698
n12:16091761
wdt:P698
16091761
p:P1433
wds:Q36615251-C189A7FE-490E-48AC-AD4E-3B2A1685D464
wdt:P1433
wd:Q326309
p:P433
wds:Q36615251-C9FF2350-195E-4B6A-B4A3-617E94BE7B62
p:P478
wds:Q36615251-9311779D-4859-4AEA-9F91-B6D07EBFEA0F
wdt:P433
5
wdt:P478
93
p:P356
wds:Q36615251-FD955570-915E-45A9-ADEB-3814E86A9498
wdtn:P356
n6:SJ.BJC.6602732
wdt:P356
10.1038/SJ.BJC.6602732
p:P5875
wds:Q36615251-DF1F8617-1191-4368-8340-0133CD2B9F93
wdt:P5875
7668137
p:P932
wds:Q36615251-6D1F49A2-28CF-4108-A2A0-1B13B873F7DD
wdt:P932
2361597